Prime Medicine to Participate in Upcoming Investor Conferences Feb 25, 2026 08:00AM
Prime Medicine closes $144.2 million public offering Aug 1, 2025 04:01PM
Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares Aug 1, 2025 04:01PM
Prime Medicine Announces Pricing of Public Offering Jul 30, 2025 09:33PM
Prime Medicine announces public offering of common stock Jul 30, 2025 04:01PM


Jul 30, 2025 04:01PM Prime Medicine Announces Proposed Public Offering of Common Stock
Jul 30, 2025 04:01PM Prime Medicine Announces Proposed Public Offering of Common Stock
Feb 24, 2025 08:00AM Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference
Jan 6, 2025 10:35AM TD Cowen: '10 Potential "Thome Run" Catalysts to Watch in 2025'
Sep 30, 2024 03:06PM TD Cowen Reiterates Buy Rating on Prime Medicine (PRME)
Apr 8, 2024 06:15AM TD Cowen Starts Prime Medicine (PRME) at Buy
Feb 28, 2024 08:00AM Prime Medicine to Participate in Upcoming Investor Conferences
Feb 20, 2024 04:01PM Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Feb 15, 2024 03:52AM Prime Medicine (PRME) Prices Upsized 19.2M Share Offering at $6.25/sh
Feb 14, 2024 11:50PM Prime Medicine Announces Pricing of Upsized Public Offering
Feb 14, 2024 04:05PM Prime Medicine (PRME) Announces Proposed $125M Share Offering
Feb 14, 2024 04:05PM Prime Medicine Announces Proposed Public Offering of Common Stock
Feb 27, 2023 08:00AM Prime Medicine to Present at Cowen 43rd Annual Health Care Conference
Feb 27, 2023 08:00AM Prime Medicine to Present at Cowen 43rd Annual Health Care Conference